Role of effector cell-derived Il-4, Il-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 424-434

  Dobrzanski, M J ^a   Reome, J B ^a   Dutton, R W ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 5; PERFORIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; GENETIC DISORDER; INTERFERON PRODUCTION; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN SECRETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TC2 CELL; TUMOR LOCALIZATION; TUMOR REGRESSION; TUMOR REJECTION;

EID: 0035399599     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.424     Document Type: Article

References (63)

1. Therapeutic vaccination for cancer
2. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2: Role of interleukin 5
3. Suppression of in vivo tumor growth by the transfection of the IL-5 gene into colon tumor cells
4. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhance antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory
5. Murine interleukin-4 displays potent anti-tumor activity in vivo
6. An eosinophil-dependent mechanism for the antitumor effect of IL-4
7. An efficient Th2-type memory follows CD8 lymphocyte-driven and eosinophil-mediated rejection of a subcutaneous mouse mammary adenocarcinoma engineered to produce IL-4
8. The central role of CD4 T cells in the antitumor immune response
9. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer
10. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo
11. Interaction between chemokines and other cytokines in host responses to tumor
12. The role of CCR7 in Th1 and Th2 cell localization and delivery of B cell help in vivo
13. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cell (Th1s) and Th2s
14. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
15. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
16. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
17. + T cell subpopulations in established pulmonary metastases
18. Type 1 and type 2 CD8 effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumors
19. Immunopotentiating role of IFN-γ in early and late stages of type 1 CD8 effector cell-mediated tumor rejection
20. Generation of polarized antigen specific CD8 effector populations: Reciprocal actions of IL-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
21. Cytokine induced differentiation of precursor mouse CD8 T cells into cytotoxic CD8 T cells secreting Th1 or Th2 cytokines
22. Perforin and Fas killing by CD8 T cells limit their cytokine synthesis and proliferation
23. Allospecific CD8 Tc1 and Tc2 populations in graft versus leukemia effect and graft versus host disease
24. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations
25. Human Tc1 and Tc2/Tc0 CD8 T cell clones display distinct cell surface and functional phenotypes
26. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
27. Th2-like CD8 T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection
28. Functional characterization and modulation of cytokine production by CD8 T cells from human immunodeficiency virus-infected individuals
29. T cell receptor antagonistic peptides induce positive selection
30. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, 5 using modified cDNA expression vectors
31. Correlation and regression
32. Phenotypic analysis of antigen-specific T lymphocytes
33. T cell memory
34. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
35. Regulation of cytotoxic T lymphocytes generation by B cell stimulatory factor
36. B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2-resting murine T lymphocytes
37. Interleukin-5, eosinophils and disease
38. Interleukin-5 and its receptor system: Implications in the immune system and inflammation
39. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
40. Differential modulation of interleukin-4 and interleukin-13 secretion from human peripheral blood mononuclear cells
41. Antigen-specific regulation of T cell-mediated cytokine production
42. The T cell-specific CXC chemokines IP-10, MIG, and I-TAC are expressed by activated human bronchial epithelial cells
43. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potentially induces eotaxin expression by airway epithelial cells
44. T helper cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages
45. Expression of CXCR4 in eosinophils: Functional analyses and cytokine-mediated regulation
46. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes
47. Inducible expression of a Th2-type CC-chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells
48. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastases of murine B16 melanoma
49. Spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice
50. Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell responses from a type 2 to a type 1 cytokine profile
51. Cutting edge: Differentiation of antitumor CTL in vivo requires host expression of Stat 1
52. Demonstration of an interferon-γ-dependent tumor surveillance system in immunocompetent mice
53. Sequential development of structural and functional alterations T cells from tumor-bearing mice
54. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
55. CTLA-4 blockade reverses CD8 T cell tolerance to tumor by a CD4 T cell and IL-2-dependent mechanism
56. Spontaneous apoptosis of CD8 T lymphocytes in peripheral blood of patients with advanced melanoma
57. Gr-1 myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
58. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells
59. Tetramer-guided analysis of TCR β-chain usage reveals a large repertoire of melan-A-specific CD8 T cells in melanoma patients
60. Oligoclonal expansion of CD8 T cells in chronic HIV infection are antigen specific
61. Examination of CD8 T cell function in humans using MHC class I tetramers: Similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8 T cells specific to a single viral epilope
62. T cell memory: Heterogeneity and mechanisms
63. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients